Please assess the completion status of the following clinical trial:

Trial Title: The OBSTACLE Hypoglycemia Study (MK-0000-158)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with Type 2 Diabetes, of either gender and aged between 18-75 years~* Patients being considered for addition of Sulfonylurea on background of at least one other oral hypoglycemic agent, on a usual visit (screening cum enrolment visit), as per the clinical situation judged by participating physician~* Willing to comply with study requirements~Exclusion Criteria:~* Patients with type 1 Diabetes or gestational Diabetes~* Patients currently on insulin therapy or have received Insulin in last 6 months~* Patients currently on Sulfonylurea therapy or have received Sulfonylureas in last 6 months~* Patients currently on Meglitinides therapy or have received Meglitinides in last 6 months~* Patients initiated on Sulfonylurea monotherapy~* Patient on DPP-4 inhibitors, either as monotherapy or as combination therapy~* Patient is, at the time of signing informed consent, a user of recreational or illicit drugs or has had a recent history (within the last year) of drug or alcohol abuse or dependence.~* Patients for whom it would be impossible to complete the questionnaire for whatever reason, in any feasible form~* Patients who are already participating in a clinical trial or other clinical study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- All participants (Type: None): Participants with type 2 diabetes mellitus (T2DM) who had sulfonylurea treatment added to an on-going regime of oral hypoglycemic agent(s).

Based on this trial design, predict the completion outcome and termination type (if applicable).